Kelly D Moynihan

11PUBLICATIONS
79CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 02, 2024
CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool.

Paulien Kaptein, Nadine Slingerland, Christina Metoikidou

|Apr 02, 2024
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity.

Kelly D Moynihan, Manu P Kumar, Hussein Sultan

|Jan 10, 2024
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus.

Francesco Andreata, Kelly D Moynihan, Valeria Fumagalli

|Mar 15, 2023
Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression.

Zachariah P Tritz, Katayoun Ayasoufi, Delaney M Wolf

|Aug 01, 2022
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.

Coralie M Backlund, Rebecca L Holden, Kelly D Moynihan

|Apr 15, 2021
Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice.

Byong H Kang, Noor Momin, Kelly D Moynihan

Pageof 2

Frequent Collaborators

4 joint publications

Darrell J Irvine

2 joint publications

Danielle C Pappas

2 joint publications

Yik A Yeung

2 joint publications

Henry C Nguyen